Merck drug could be available in China by end of… State-owned drug maker says ‘hundreds of thousands’ of boxes of molnupiravir have arrived and more are being…
Sinopharm ‘hopes to make new vaccine available… Hong Kong on Monday reports 1,841 new coronavirus cases, of which 196 were imported, and no additional related…
China vaccine stocks get market jolt as rivalry,… Since a 55 per cent breakout in early last year, China’s top vaccine producers have slumped from Shanghai to…
Hong Kong approves trials for 3 Chinese vaccines… Sinovac Biotech and China National Biotec Group have received approval to carry out clinical trials in the city for…
South African health regulator registers… South Africa’s health regulator has registered the Sinopharm Covid-19 shot, clearing the way for the Chinese…
China’s top Covid-19 expert urges stronger… China has built a certain level of herd immunity against Covid-19 but will need to boost its power to fight…
Sinopharm protein-based booster stronger against… A protein-based Covid-19 booster vaccine made by Sinopharm elicited a stronger antibody response against the…
Which vaccines stop Omicron? Search for data… This is the second of a two-part series on the impact of the Omicron variant on vaccine roll-outs around the world.…
Covid-19 booster from China’s Sinopharm is… A Covid-19 vaccine booster shot by China’s Sinopharm showed significantly weaker neutralising activity against the…
Omicron evades protection from 2 doses of… The Omicron variant of the coronavirus evades immunity offered by an inactivated Covid-19 vaccine developed by…